IMP
Process View
nerve growth factor signaling pathway
A series of molecular signals initiated by the binding of nerve growth factor (NGF) to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "nerve growth factor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 1.000 | ||
| GGA2 | golgi-associated, gamma adaptin ear containing, ARF binding protein 2 | 0.909 | ||
| SORT1 | sortilin 1 | 0.747 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.679 | ||
| GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | 0.597 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.594 | Rat | |
| SYNRG | synergin, gamma | 0.559 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.496 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.484 | Human | |
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.459 | Human | |
| ADRB1 | adrenergic, beta-1-, receptor | 0.366 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.303 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.301 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.292 | Rat | |
| PLCG1 | phospholipase C, gamma 1 | 0.226 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.220 | Mouse | |
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.183 | ||
| SORL1 | sortilin-related receptor, L(DLR class) A repeats containing | 0.163 | Human | |
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.123 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.072 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.066 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.065 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.055 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.048 | ||
| SPG21 | spastic paraplegia 21 (autosomal recessive, Mast syndrome) | 0.042 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.031 | ||
| ATP8 | ATP synthase F0 subunit 8 | 0.028 | ||
| RABEP1 | rabaptin, RAB GTPase binding effector protein 1 | 0.025 | ||
| ITSN2 | intersectin 2 | 0.024 | ||
| RAP1A | RAP1A, member of RAS oncogene family | 0.024 | Rat | |
| WASL | Wiskott-Aldrich syndrome-like | 0.021 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.020 | ||
| DNM1 | dynamin 1 | 0.016 | ||
| CTTNBP2NL | CTTNBP2 N-terminal like | 0.016 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.015 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.015 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.014 | ||
| SECISBP2L | SECIS binding protein 2-like | 0.014 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.012 | ||
| ABI1 | abl-interactor 1 | 0.012 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.010 | ||
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.010 |